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Abstract
Introduction: Our objective was to report a case of misdiagnosed temporal lobe necrosis (TLN) in a patient with
nasopharyngeal cancer (NPC) after radiation therapy.
Case Presentation: We report a case of a 45 years old Chinese woman who developed moderate to severe
headache and dizziness 1 year after 2D radiation therapy for NPC. Subsequent MRI scanning revealed a big
enhancing mass in the right temporal lobe. The initial diagnosis was metastatic or intracranial extension of NPC, or
a primary intracranial malignancy. She was referred to the neurosurgery department where a maximal surgical
resection of the lesion was performed. A diagnosis of TLN was made according to the final histology.
Conclusion: TLN still matters in the IMRT era. The diagnostic quagmire of TLN lies in its close resemblance to
neoplasm on clinical presentation and imaging. Reviewing the patient’s treatment plan to scrutinize the dose to
the temporal lobes is an important prerequisite for diagnosis.
Introduction
Worldwide, nasopharyngeal cancer (NPC) is most com-
mon in South China in the provinces of Guangdong,
Guangxi, Fujian, Hunan, and Hong Kong. Its incidence
in these regions is 30 per 100,000 compared to just 1
per 100,000 in Europe [1]. Radiation therapy remains
the main modality of treatment in NPC patients because
of anatomic constraints and a high degree of radiosensi-
tivity of this tumor [2-4]. However, temporal lobe necro-
sis (TLN) is one of the late side effects of radiation
therapy that may be encountered in these patients.
The first case of radiation necrosis was described by
Fischer and Holfelder in 1930 in a 45 year old patient
treated with radiotherapy for basal cell epithelioma of
the temporal region with a total dose of 6840 cGy [5].
Lee et al. reported an incidence of up to 3% of TLN in
patients after radiation therapy [6]. This entity was once
commonly encountered in the era when 2-D technique
was widely used for the treatment of NPC. A significant
decline of this complication has been observed since the
introduction of Intensity-modulated Radiation Therapy
(IMRT). Consequently, more and more physicians are
oblivious of this complication due to its present rarity.
However, knowledge about the possibility of its occur-
rence, as a delayed side effect of radiation therapy, is
vital as it is associated with high morbidity and mortal-
ity. It has been seen to account for 65% of radiation
related deaths from NPC in Hong Kong [7,8] and the
5 year survival with temporal lobe necrosis, with or
without treatment, has been reported to be around 59%
there [6].
Owing to its close proximity to the skull base, the
medial parts of bilateral temporal lobes are inevitably
included in the target volume. Since the inferior por-
tions of the temporal lobes lie within the portals of
radiation therapy, TLN is normally seen to occur in
bilateral inferomedial parts of the temporal lobes.
Differentiating this condition from metastatic or pri-
mary brain tumor remains a clinical and radiological
challenge due to their close resemblance. We hereby
report the case of a 45 year old Chinese woman with
NPC who received radiation therapy at a local hospital
using 2D technique and developed severe radiation
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missed twice but was finally established by maximal sur-
gical resection and histological examination, hence
further laying emphasis on the reduced awareness and
diagnostic dilemma of this entity.
Case presentation
A 45 year old Chinese lady with a six months history of
bilateral nasal obstruction, tinnitus, associated headache
and dizziness presented to the local hospital on Novem-
ber 3rd, 2009. Nasoendoscopy revealed a large mass in
the nasopharynx, a biopsy of which confirmed non-
keratinizing squamous cell carcinoma, WHO type 2.2
[9]. Staging MRI and CT scans showed a large tumor
measuring 5 × 3 cm occupying the roof and the poster-
ior wall of the nasopharynx which invaded the inferior
part of the clivus. Cross sectional images also revealed
bilaterally enlarged lymph nodes in the upper neck.
According to the 2002 AJCC staging system [10], she
was diagnosed as a NPC patient of stage cT3N2M0. She
was treated with 2-phase lateral opposed facial-cervical
fields at a 2 Gy daily fraction (Figure 1), 5 times a week
to a total dose of 70 Gy with concurrent cisplatin from
November 10th to December 31st, 2010. Complete
response was achieved after concurrent chemo-radio-
therapy. 3 cycles of adjuvant chemotherapy consisting of
Cisplatin and 5-fluorouracil was given following concur-
rent chemo-radiotherapy.
However, 1 year after radiation therapy the patient
developed moderate to severe headache and dizziness.
She returned to the local hospital to seek medical inter-
vention for her symptoms on March 2nd, 2010. There
was no associated history of fever, blurring of vision,
nausea or vomiting. Physical examination was unre-
markable. No abnormal neurological signs were noted.
Her hematological and biochemical profile as well as
her liver function test results were normal. However,
Brain MRI scan showed abnormalities in the white mat-
ter of bilateral inferior portions of the temporal lobes.
A large heterogeneous lesion with circumferential rim
Figure 1 2D Treatment plan showed that the inferior parts of bilateral temporal lobe received high dose irradiation.
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in the inferior part of the right temporal lobe. Small
homogeneous lesions with limited edema could also be
seen in the left temporal lobe (Figure 2, 3). However,
these findings in the contralateral temporal lobe failed
to hint the correct diagnosis at the attending physician.
Moreover, the MRI also showed associated mild white
matter demyelination and cerebral atrophy. Upon
assumption that the patient was either a case of primary
brain tumor or intracranial extension of NPC, she was
referred to the neurosurgery department at local hospi-
tal where she was advised to undergo surgery.
The patient refused surgery or any further treatment.
Subsequently, her clinical condition worsened with time.
2 months later she complained of more intense head-
ache especially in the morning with accompanying dizzi-
ness, nausea and blurring of vision, which prompted her
to return to the neurosurgery department at our hospi-
tal in May, 2010. Physical examination showed presence
of papilloedema. There was absence of neck rigidity and
other focal neurological deficits. Brain MRI re-scanning
showed no other new lesions. In keeping with the initial
diagnosis of temporal lobe malignancy, the attending
neurosurgeon performed a maximal surgical resection of
the lesion in the right temporal lobe on May 18th, 2010.
However, histological examination confirmed the
absence of neoplastic cells in the resected brain tissues.
Instead, partial liquefactive necrotic tissue with lympho-
cytic infiltration was noted. Additionally, there was asso-
ciated dilatation, congestion and hemorrhage of
surrounding blood vessels which corroborated with a
diagnosis of radiation induced TLN (Figure 4).
Fortunately, her symptoms relieved significantly after
resection of the right lesion. Postoperative MRI revealed
a big cavity in the lower portion of right temporal lobe
with surrounding edema, and several minor enhanced
lesions in the counterpart of the left temporal lobe (Fig-
ure 5). She presented to our department to seek medical
opinion about further treatment for the minor lesions in
the left temporal lobe. She was prescribed anticoagulants
and high dose vitamins. At present the patient remains
well and is in close follow-up 3 months after the TLN
resection.
Discussion
TLN, as a late potential sequalae of radiation treatment
in patients with NPC, has experienced a down slope
over the past decade. This has occurred with the grow-
ing worldwide use of IMRT for treatment of this
Figure 2 Axial gadolinium-enhanced T1-weighted images
revealed a large heterogeneous mass with circumferential rim
enhancement surrounded by extensive edema was found in
the inferior part of the right temporal lobe. Small homogeneous
lesions with limited edema could also be seen in the left temporal
lobe.
Figure 3 Coronal images also showed the same findings.
Figure 4 Histological examination confirmed the absence of
neoplastic cells in the resected brain tissues. Instead, partial
liquefactive necrotic tissue with lymphocytic infiltration was noted.
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benefit of dose escalation with reduced toxicity to nor-
mal tissues [11]. Symptoms of TLN usually appear one
to three years after the last dose of radiation treatment
with a silent latent interval noted between the end of
treatment and development of radiation-induced necro-
sis [12]. Four main types of clinical presentations were
described in a study by Lee et al. They ranged from
complete absence of symptoms to vague features of
temporal lobe damage, symptoms of temporal lobe
epilepsy or nonspecific characteristics of intracranial
lesions. The asymptomatic patients were incidentally
diagnosed during follow up with CT or MRI [7]. The
clinical progression of our patient was that of non-speci-
fic symptoms to overt symptoms of raised intracranial
pressure.
Using 2D radiotherapy technique, inferior parts of
bilateral temporal lobes almost always receive the same
dose as the tumor, especially for patients with locally
advanced disease infiltrating the skull base or cavernous
Figure 5 Postoperative axial gadolinium-enhanced T1-weighted images a big cavity in the lower portion of right temporal lobe with
surrounding edema, and several minor enhanced lesions in the counterpart of the left temporal lobe.
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developing TLN within 5 years following use of a total
dose of equal to or more than 62.5 Gy [13]. The patient
received 70 Gy to her skull base using 2D technique
which put her at a high risk of developing radiation
necrosis. IMRT, on the other hand, has the advantage of
generating complicated 3D dose distributions to con-
form closely to the target volume and the beam inten-
sity can be optimized using computer algorithms. It has
been reported that IMRT provided excellent tumor tar-
get coverage and allowed the delivery of a high dose to
the target with significant sparing of nearby critical nor-
mal tissues [14]. Hence, it plays an important role in
decreasing radiation-induced injuries in patients with
NPC [15].
The differential diagnoses of TLN include intracranial
extension of NPC, second primary intracranial neo-
plasm, cerebral metastasis, meningeal spread and brain
abscess [16]. Differentiation of tumor progression and
radiation injury after radiation therapy is indispensable
for appropriate treatment [17]. CT, MRI and PET-CT
are all useful tools for TLN diagnosis, but none is speci-
fic. The characteristic features on MRI include mass
effect, vasogenic edema and contrast enhancement.
However, MRI alone cannot reliably discriminate tumor
from radiation induced necrosis [18], even though the
latter can be associated with specific patterns of
enhancement such as “soap bubble” or “Swiss cheese”
enhancement patterns [19]. The use of functional ima-
ging like the FDG-PET and the proton MR spectroscopy
has shown some advantages in differentiating the enti-
ties. But presently, they have not been widely used due
to their high cost or complicated techniques.
A definitive diagnosis is obtained from surgical explora-
tion and biopsy or removal of the necrotic mass [16],
but this is not routinely justified. It may not strike the
doctor to include TLN as one of the differential diag-
noses if he does not review the history and treatment
plan of the patient. By carefully correlating the history,
the findings on physical examination, the laboratory
investigations with the features on imaging scans like
brain MRI and CT, a correct working diagnosis can be
confidently reached without resorting to biopsy [20-22].
In our case report, a brain abscess can be excluded as
our patient had few symptoms and signs to support an
infectious disease. Ruling out hematogenous spread of
NPC is easy, as it is very rare and would unlikely be pre-
sent bilaterally [23], while tumor extension is usually
associated with erosion of the skull base. Hence, radia-
tion induced necrosis as diagnosis for our patient is sup-
ported by the fact that the symptoms developed
6 months after treatment, there was no history of asso-
ciated fever and the physical findings were consistent
with mass effect of the lesion, and last but not the least,
the lesions on MRI were bilateral, involving the inferior
portions of the temporal lobes, which are usually
included in the portals of radiation. However, in our
case, this diagnosis may have evaded the attending doc-
tor due to its dwindling existence and close similarity to
brain tumor and failure to correlate the bilateralism of
the lesions with the treatment plan.
Traditional treatment for TLN includes the use of
steroids, hyperbaric oxygen, antiplatelets, anticoagulants,
high dose vitamins and surgery, but all have shown a
limited efficacy [12,24]. Steroids have been used to pro-
vide prompt symptomatic relief and help in retarding
the pathologic process [25]. Surgery is used as the last
resort palliative measure in patients with significant
increase in intracranial pressure or in those who have
progressive neurologic deficits despite steroids or other
medical therapy. However, in NPC patients who usually
have bilateral temporal lobe involvement, surgery can be
hazardous. The possible risk of Kluver Bucy syndrome is
of concern when considering bilateral temporal lobect-
omy [7]. The advent of bevacizumab, a humanized
monoclonal antibody that inhibits vascular endothelial
growth factor (VEGF) has paved the way to possibilities
of reversing the pathogenesis of TLN and providing per-
manent results. Evidence is now available that justifies
the consideration of its use in the treatment of radiation
necrosis secondary to treatment of head and neck
cancers [26-28].
Conclusion
Although TLN has been dwindling since the introduc-
tion of IMRT, it should always be kept in mind when
encountering temporal lobe lesions in NPC after radia-
tion therapy. The diagnostic quagmire of TLN lies in its
close resemblance to neoplasm on clinical presentation
and imaging appearance. This can be achieved by com-
bining the history, physical examination findings, with
abnormalities seen on imaging tools like MRI.
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